Medinotec Inc. approved to trade on OTCQX Best Market under symbol MDNC

Medinotec Inc.

OTC Markets notified Medinotec on March 30, 2023; trading on OTCQX began March 31, 2023.
Company qualifies for OTCQX by meeting high financial standards and corporate governance requirements.
B. Riley Securities acted as OTCQX sponsor for the upgrade.
CEO Gregory Vizirgianakis cited increased exposure and commitment to shareholder value.
Medinotec plans to expand US sales, initially focusing on its Trachealtor device (2021 MDEA gold winner).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.